Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-GLucose coTransporter-2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06201000
What this trial is testing

Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients

Who this might be right for
Genetic PolymorphismsHeart Failure
October 6 University 282
Post-approval studies (Phase 4)UnknownNCT05975528
What this trial is testing

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Who this might be right for
Diabetes MellitusCellular SenescenceSodium-Glucose Transporter 2 Inhibitors
Yonsei University 92
Post-approval studies (Phase 4)Looking for participantsNCT06674109
What this trial is testing

SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial

Who this might be right for
Gout and Hyperuricemia
Massachusetts General Hospital 60
Post-approval studies (Phase 4)WithdrawnNCT02768220
What this trial is testing

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

Who this might be right for
SGLT-2 InhibitorsAdvanced Glycation End ProductsDiabetes
Northwell Health
Post-approval studies (Phase 4)Not Yet RecruitingNCT07351864
What this trial is testing

Finerenone Plus SGLT2 Inhibitors in Heart Failure

Who this might be right for
Heart Failure
Mansoura University 60
Early research (Phase 1)Looking for participantsNCT06753994
What this trial is testing

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Who this might be right for
DiabetesType1diabetesT1D
McGill University 24
Very early researchUnknownNCT05512130
What this trial is testing

Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy

Who this might be right for
Epilepsy
Washington University School of Medicine 18
Post-approval studies (Phase 4)Study completedNCT06825156
What this trial is testing

Metabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 Inhibitors

Who this might be right for
Acute Kidney Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Not applicableStudy completedNCT03748810
What this trial is testing

Head-to-head Comparison of Empagliflozin and Dapagliflozin

Who this might be right for
Type2 Diabetes
Chungbuk National University Hospital 600
Not applicableStudy completedNCT04017221
What this trial is testing

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2UrosepsisDiabetic Ketoacidosis+1 more
Canadian Network for Observational Drug Effect Studies, CNODES 1,249,636
Not applicableActive Not RecruitingNCT05999773
What this trial is testing

SGLT-2 Inhibitors in the Treatment of Ascites

Who this might be right for
Ascites HepaticCirrhosis, LiverDiabete Type 2
University of Palermo 40
Not applicableStudy completedNCT07022379
What this trial is testing

Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program

Who this might be right for
Heart FailureHeart Failure With Preserved Ejection Fraction (HFPEF)Heart Failure With Reduced Ejection Fraction+1 more
Satelia 13,660
Early research (Phase 1)Looking for participantsNCT07172971
What this trial is testing

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Vanderbilt University Medical Center 10
Not applicableStudy completedNCT05990296
What this trial is testing

Evaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure Care

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection Fraction
Geisinger Clinic 4,306
Post-approval studies (Phase 4)Study completedNCT06012279
What this trial is testing

Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)

Who this might be right for
Acute Heart Failure
Cairo University 117
Not applicableUnknownNCT06007157
What this trial is testing

Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 Diabetes

Who this might be right for
Blood PressureSalt; ExcessDiabete Type 2
Azienda Ospedaliero, Universitaria Pisana 30
Very early researchLooking for participantsNCT05057806
What this trial is testing

SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

Who this might be right for
Type2 DiabetesHeart Failure With Preserved Ejection Fraction
The University of Texas Health Science Center at San Antonio 30
Large-scale testing (Phase 3)Study completedNCT06469645
What this trial is testing

The Role of SGLT2i in Management of Moderate AS

Who this might be right for
Moderate Aortic Valve Stenosis
University of East Anglia 104
Testing effectiveness (Phase 2)Looking for participantsNCT06435156
What this trial is testing

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHeart Failure
University of Dundee 320
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Next Page